Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Teva Pharmaceutical Indus...

    NYSE: TEVA · Real-Time Price · USD
    17.66
    -0.40 (-2.21%)
    At close: Aug 19, 2025, 1:49 PM

    Teva Pharmaceutical Industries Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 16.54B 15.85B 14.93B 15.88B
    Cost of Revenue
    		 8.48B 8.2B 7.95B 8.28B
    Gross Profit
    		 8.06B 7.65B 6.97B 7.59B
    Operating Income
    		 -303M 433M 2.8B 3.2B
    Interest Income
    		 n/a 68M 920M 891M
    Pretax Income
    		 -1.28B -624M -3.06B 658M
    Net Income
    		 -1.64B -559M -2.35B 417M
    Selling & General & Admin
    		 3.7B 3.5B 3.44B 3.53B
    Research & Development
    		 998M 953M 838M 967M
    Other Expenses
    		 3.67B 2.76B n/a n/a
    Operating Expenses
    		 8.37B 7.21B 4.28B 4.5B
    Interest Expense
    		 n/a 1.03B 966M 1.06B
    Selling & Marketing Expenses
    		 2.54B 2.34B 2.27B 2.43B
    Cost & Expenses
    		 16.85B 15.41B 12.23B 12.78B
    Income Tax Expense
    		 676M -7M -638M 211M
    Shares Outstanding (Basic)
    		 1.13B 1.12B 1.11B 1.1B
    Shares Outstanding (Diluted)
    		 1.13B 1.12B 1.11B 1.11B
    EPS (Basic)
    		 -1.45 -0.5 -2.12 0.38
    EPS (Diluted)
    		 -1.45 -0.5 -2.12 0.38
    EBITDA
    		 777M 1.57B -874M 4.41B
    EBIT
    		 -282M 405M -2.23B 1.55B
    Depreciation & Amortization
    		 1.06B 1.15B 1.31B 1.33B

    Add to Watchlist